|Articles|May 2, 2015
Jasmine Martin Discusses Oral Adherence
Author(s)Jasmine Martin
Jasmine Martin, Director, West Region Medical Science Liaison Team, Takeda Oncology, discusses oral adherence.
Advertisement
Jasmine Martin, Director, West Region Medical Science Liaison Team, Takeda Oncology, discusses oral adherence.
“If patients aren’t taking their drugs, then how do we know that the outcomes will be [the same as] what the clinical trial [outcomes] were?” Martin asks.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on CURE
1
Inside the ‘Weird and Wacky’ Frontier of New Targeted Therapy for Lung Cancer
2
FDA Approves Epkinly Combo in Relapsed/Refractory Follicular Lymphoma
3
Understanding Emerging Cell Therapy in Lung Cancer
4
Targeted Therapies Are Transforming Lung Cancer Treatment
5
